Dr. Makoto Senoo started his research career as a post-doctoral research fellow at Harvard Medical School in 2002. He then opened his own research laboratory at the University of Pennsylvania School of Veterinary Medicine. Subsequently, he moved to the Boston University School of Dental Medicine and continued working on the p63 biology since its discovery in 1998. After 20 years of stay in the US, Dr. Senoo returned to Japan in late 2022, where he focuses on the development and manufacturing of stem cell- and exosome-mediated therapeutic strategies.
Title : The transcription factor p63 in stem cell self-renewal and cancer development
Title : Stem cells in regeneration and cancer of epithelia
Title : Transcription Factor p63 and Stem Cell Diseases